Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Mometasone Furoate Nasal Spray in Seasonal Allergic Rhinitis
NCT02125253Phase 3Completed
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Amneal Pharmaceuticals, Inc.. Started Jan 2014; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02125253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125253.